Europe Ureteral Stents Market

Europe Ureteral Stents Market Size (2022 to 2027):

The European Ureteral Stents market size was valued at USD 111.96 Million in 2022 and is expected to reach USD 152.80 Million by 2027, to grow with a strong CAGR of 6.42% during the analysis period 2022 to 2027.

Drivers

In the United Kingdom, nearly 3000 new cases were registered for kidney transplantations. According to the Global Observatory on Donation and Transplantation, nearly 89,823 kidney transplant surgeries were executed in 2016, with an increase of 6.5% since 2015. Incrementing occurrences of urological disorders attributed to the expansion of micro-organisms, quick adoption of sedentary lifestyle changes, and incrementing the number of kidney transplants are factors that pull up market growth. The rise in the aging population, frequent rise in medical conditions that require ureteral stents, and intensifying number of kidney stones are amplifying the business growth in the region. Nearly 1,000 children are with chronic kidney diseases in the U.K.

Restrains

However, a stent in the kidneys may cause difficulty and pain post-treatment, which hinders the market growth. The scarcity of skilled professionals and the rise in side effects issues negatively impact the ureteral stents market.

This research report on the Europe Ureteral Stents Market has been segmented and sub-segmented into the following categories:

By Type:

• Expandable Stent
• Double pigtail stent (JJ Stent))

By Patients Sex:

• Male
• Female

By End User:

• Hospital
• Clinical

By Medical Situation:

• Kidney Stones
• Kidney Failures
• Tumors

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regional Analysis

Germany is expected to dominate the Ureteral stents market during the analysis period. The market is driven by factors like an increase in senior citizens as there may be around 28million people aged 60 years and above living in Germany. By 2030, the aging population is expected to grow, and by 2050, nearly 38% of the elderly people are expected to have significant growth. With an increasing number of chain smokers and obese people, the growing acquisition of less minimum invasive surgeries is expected to propel business growth.

In 2019 Germany, 25.9 kidney transplants were implemented per million. Around 10.3 thousand patients are on the waiting list to undergo a kidney transplant in Germany. Among the antecedent two years, the active number of patients waiting for a kidney transplant is decreasing slowly.

The United Kingdom is projected to have a substantial ureteral stents market in the region. The flourishing count of renal transplants, increasing concerns pertaining to renal abnormalities have intensified the market demand. The rest of Europe is estimated to have a promising growth rate during the analysis period.

According to the published report by NHS Blood and Transplant, approximately 4,915 people were adults in the U.K. in 2017. Around 3million people in the U.K. are diagnosed with chronic kidney diseases (CKD). Currently, 63,000 people in the U.K. are being treated for kidney failure, and also, every day, 20 people are diagnosed with kidney failure in the U.K. 

Promising Companies leading the European Ureteral Stents Market Profiled in the Report are UteraC. R. Bard, Inc., Penn Medical, Cook Medical Inc., Boston Scientific Corporation, and Medline Industries, Inc.